Vi polysaccharide and conjugated vaccines afford similar early, IgM or IgG-independent control of infection but boosting with conjugated Vi vaccines sustains the efficacy of immune responses

Authors

Siân Jossi

Published

January 3, 2023

Share your thoughts on this paper...

Supporters

Support the authors with ResearchCoin

Preprint Server

Topics

DOI

10.1101/2023.01.03.522561

License

cc-no

Vi polysaccharide and conjugated vaccines afford similar early, IgM or IgG-independent control of infection but boosting with conjugated Vi vaccines sustains the efficacy of immune responses

Authors

Siân Jossi

Published

January 3, 2023

Share your thoughts on this paper...

Supporters

Support the authors with ResearchCoin

Preprint Server

Topics

DOI

10.1101/2023.01.03.522561

License

cc-no

Supporters

Support the authors with ResearchCoin

Preprint Server

Topics

DOI

10.1101/2023.01.03.522561

License

cc-no

Paper

Paper

Paper

Paper

Vi polysaccharide and conjugated vaccines afford similar early, IgM or IgG-independent control of infection but boosting with conjugated Vi vaccines sustains the efficacy of immune responses

Supporters

Preprint Server

Topics

DOI

License

Vi polysaccharide and conjugated vaccines afford similar early, IgM or IgG-independent control of infection but boosting with conjugated Vi vaccines sustains the efficacy of immune responses

Supporters

Preprint Server

Topics

DOI

License

Supporters

Preprint Server

Topics

DOI

License